Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18,578,488
-
Total 13F shares
-
1,065,645
-
Share change
-
+1,065,645
-
Total reported value
-
$3,015,000
-
Price per share
-
$2.83
-
Number of holders
-
9
-
Value change
-
+$3,015,000
-
Number of buys
-
9
Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q3 2021
As of 30 Sep 2021,
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,065,645 shares.
The largest 9 holders included
Nantahala Capital Management, LLC, Board of Trustees of The Leland Stanford Junior University, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, SANDERS MORRIS HARRIS LLC, Frontier Wealth Management LLC, TANDEM CAPITAL MANAGEMENT CORP /ADV, BlackRock Inc., and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.